Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification

Nature Clinical Practice Cardiovascular Medicine volume 3, pages S114–S122 (2006)Cite this article

Abstract

Embryonic stem cells (ESCs) can be propagated indefinitely in culture, while retaining the ability to differentiate into any cell type in the organism. The molecular and cellular mechanisms underlying ESC pluripotency are, however, poorly understood. We characterize a population of early mesoderm-specified (EM) progenitors that is generated from mouse ESCs by bone morphogenetic protein stimulation. We further show that pluripotent ESCs are actively regenerated from EM progenitors by the action of the divergent homeodomain-containing protein Nanog, which, in turn, is upregulated in EM progenitors by the combined action of leukemia inhibitory factor and the early mesoderm transcription factor T/Brachyury. These findings uncover specific roles of leukemia inhibitory factor, Nanog, and bone morphogenetic protein in the self-renewal of ESCs and provide novel insights into the cellular bases of ESC pluripotency.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Leukemia inhibitory factor regulates the percentage of T-expressing cells in mouse embryonic stem cell cultures
Figure 2: Dedifferentiation of lineage-specified mesoderm progenitors into pluripotent stem cells
Figure 3: Nanog is sufficient and necessary for dedifferentiation of early mesoderm-specified progenitors into pluripotent stem cells
Figure 4: Maintenance of embryonic stem cell pluripotency by a negative feedback involving Nanog and T

Similar content being viewed by others

References

  1. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634–7638

    Article  CAS  Google Scholar 

  2. Evans MJ and Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154–156

    Article  CAS  Google Scholar 

  3. Smith AG (2001) Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17: 435–462

    Article  CAS  Google Scholar 

  4. Shamblott MJ et al. (1998) Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 95: 13726–13731

    Article  CAS  Google Scholar 

  5. Thomson JA et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147

    Article  CAS  Google Scholar 

  6. Rao M (2004) Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Dev Biol 275: 269–286

    Article  CAS  Google Scholar 

  7. Herrmann BG et al. (1990) Cloning of the T gene required in mesoderm formation in the mouse. Nature 343: 617–622

    Article  CAS  Google Scholar 

  8. Wilkinson DG et al. (1990) Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 343: 657–659

    Article  CAS  Google Scholar 

  9. Smith AG et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336: 688–690

    Article  CAS  Google Scholar 

  10. Williams RL et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684–687

    Article  CAS  Google Scholar 

  11. Mitsui K et al. (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631–642

    Article  CAS  Google Scholar 

  12. Chambers I et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643–655

    Article  CAS  Google Scholar 

  13. Li E et al. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915–926

    Article  CAS  Google Scholar 

  14. Cowan CA et al. (2004) Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350: 1353–1356

    Article  CAS  Google Scholar 

  15. Yu D et al. (2000) An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci USA 97: 5978–5983

    Article  CAS  Google Scholar 

  16. Suzuki A et al. (2000) Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology 32: 1230–1239

    Article  CAS  Google Scholar 

  17. Suzuki A et al. (2003) Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development 130: 2513–2524

    Article  CAS  Google Scholar 

  18. Ramalho-Santos M et al. (2002) “Stemness”: transcriptional profiling of embryonic and adult stem cells. Science 298: 597–600

    Article  CAS  Google Scholar 

  19. Raz R et al. (1999) Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci USA 96: 2846–2851

    Article  CAS  Google Scholar 

  20. Gossen M et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766–1769

    Article  CAS  Google Scholar 

  21. Hoffmann A et al. (2002) The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J Cell Sci 115: 769–781

    CAS  PubMed  Google Scholar 

  22. Rashbass P et al. (1991) A cell autonomous function of Brachyury in T/T embryonic stem cell chimaeras. Nature 353: 348–351

    Article  CAS  Google Scholar 

  23. Kubo A et al. (2004) Development of definitive endoderm from embryonic stem cells in culture. Development 131: 1651–1662

    Article  CAS  Google Scholar 

  24. Rathjen J et al. (1999) Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell Sci 112 (Pt 5) 601–612

    CAS  PubMed  Google Scholar 

  25. Nichols J et al. (2001) Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 128: 2333–2339

    CAS  Google Scholar 

  26. Daheron L et al. (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22: 770–778

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank R Benezra, S Choe, NG Copeland, R Eckner, D Melton, K Miyazono, G Tiscornia, and S Yamanaka for reagents; D Buscher, C Kintner, I Oishi, J Sonoda, and A Tashiro for helpful suggestions; H Pineda, T Chapman, and H Juguilon for technical assistance; and M-F Schwarz for help with this manuscript. AS, TM, and KN received support from the Japan Society for the Promotion of Science, and AR and CR-E from the Fundación Inbiomed, Spain. We are also indebted for support to the Salk Institute, the Lookout Fund, the G Harold and Leila Y Mathers Charitable Foundation, and the National Institutes of Health.

Author information

Authors and Affiliations

  1. Salk Institute for Biological Studies, La Jolla, CA, USA

    Atsushi Suzuki, Ángel Raya, Yasuhiko Kawakami, Masanobu Morita, Takaaki Matsui, Kinichi Nakashima, Fred H Gage, Concepción Rodríguez-Esteban & Juan Carlos Izpisúa Belmonte

  2. Laboratory of Molecular Neuroscience, Nara Institute of Science and Technology, Ikoma, Japan

    Atsushi Suzuki, Ángel Raya, Yasuhiko Kawakami, Masanobu Morita, Takaaki Matsui, Kinichi Nakashima, Fred H Gage, Concepción Rodríguez-Esteban & Juan Carlos Izpisúa Belmonte

  3. Research Unit for Organ Regeneration, Center for Developmental Biology, Kobe, Japan

    Atsushi Suzuki, Ángel Raya, Yasuhiko Kawakami, Masanobu Morita, Takaaki Matsui, Kinichi Nakashima, Fred H Gage, Concepción Rodríguez-Esteban & Juan Carlos Izpisúa Belmonte

  4. Center of Regenerative Medicine, Barcelona, Spain

    Atsushi Suzuki, Ángel Raya, Yasuhiko Kawakami, Masanobu Morita, Takaaki Matsui, Kinichi Nakashima, Fred H Gage, Concepción Rodríguez-Esteban & Juan Carlos Izpisúa Belmonte

  5. Graduate School of Biological Sciences, Nara Institute of Science and Technology, Takayama, Ikoma, Japan

    Atsushi Suzuki, Ángel Raya, Yasuhiko Kawakami, Masanobu Morita, Takaaki Matsui, Kinichi Nakashima, Fred H Gage, Concepción Rodríguez-Esteban & Juan Carlos Izpisúa Belmonte

Authors
  1. Atsushi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ángel Raya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhiko Kawakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masanobu Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takaaki Matsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kinichi Nakashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fred H Gage
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Concepción Rodríguez-Esteban
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Juan Carlos Izpisúa Belmonte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Carlos Izpisúa Belmonte.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, A., Raya, Á., Kawakami, Y. et al. Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat Rev Cardiol 3 (Suppl 1), S114–S122 (2006). https://doi.org/10.1038/ncpcardio0442

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0442

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing